Scientific Advisory Board

CIRI has got a Scientific Advisory Board, which includes international-rank microbiologists and immunologists. Its members are chosen by the unit's Direction Committee for their scientific expertise, their strategic vision of research and their knowledge of the biopharmaceutical industry. The board advises CIRI on programs in development, its strategical choices, the evolution of teams and their projects, as well as quality of transversal projects and hosting requests or the creation of teams.

Scientific advisory boards's Composition 2023:

Alain Filloux, (President), Professor at Nanyang Technological University, Singapore, SGP 
Ali Saib, (Vice-President), Conseiller Court of Auditors / Cour des Comptes SAB, FRA

Benjamin Berkhout, Professor of Human Retrovirology, UMS Amsterdam, NLD

Camille Locht, Emerite Research Director Inserm, Centre d’Infection et d’Immunité de Lille, FRA
Christian Münz, Professor at Univ. Of Zurich, CHE

Marc Bonneville, Scientific and Medical Director at Institut Mérieux Lyon, FRA

Massimo Palmarini, Professor at University of Glasgow, GBR
Hamida Hammad, Professor at Univ. of Ghent, BEL
Julie Déchanet-Merville,  Research Director CNRS, ImmunoConcEpT, Bordeaux, FRA
Stephan Becker, Professor Dr at Univ. of Marburg, DEU 
Thomas Schulz,  Professor of Virology at Hannover Medical School, DEU 

SAB from  February 10th and 11th 2025

Scientific advisory boards's Composition  (2019-2023):

Jean-Luc Imler (Président, Strasbourg);
Ali Saib (Vice-Président, Paris);
Christian Münz (Switzerland)
Marc Bonneville (Lyon);
Hamida Hamad (Belgique);
Ana-Maria Lennon-Dumenil (Paris)
Alain Filloux (UK);
Camille Locht (Lilles);
Philippe Moreillon (Switzerland)
Thomas Schulz (Germany)
Stephan Becker (Germany);
Ben Berkhout (Netherland);
Massimo Palmarini (Scotland)